About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Uveal Melanoma - Comparative Study | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT06284512

Uveal Melanoma - Comparative Study

The progress of uveal melanoma is typically monitored with sonography by experienced onco-ophthalmologists. However, there is evidence that twodimensional measurements in color fundus photography matc...

Lead sponsor: Medical University of Vienna•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Reinhard Told, MD, PhD, Priv.-Doz.

CONTACT

+43 40400 79690 reinhard.told@meduniwien.ac.at

Judith Kreminger, MD

CONTACT

+43 40400 48470 judith.kreminger@meduniwien.ac.at

Sponsors

Lead Sponsor

Medical University of Vienna

Age

18 - 99 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of uveal melanoma

Exclusion Criteria

•Inadequate or missing information on the clinical course in patient charts
•Imaging not feasible due to any reason.

Related studies

RECRUITINGPhase 1

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

NCT07076550 · Melanoma Metastatic, Uveal Melanoma, Metastatic, and more

RECRUITINGPhase 3

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

NCT06007690 · Choroidal Melanoma, Indeterminate Lesions, and more

RECRUITINGPhase 2/3

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

NCT06581406 · Metastatic Uveal Melanoma

RECRUITINGPhase 1

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

NCT05607095 · Uveal Melanoma, Melanoma, and more

RECRUITINGPhase 1/2

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

NCT03947385 · Metastatic Uveal Melanoma, Cutaneous Melanoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 29, 2024Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment50

Start dateOct 2023

Last updatedFeb 29, 2024

Condition

Locations shown

Medical University of Vienna, Department of Ophthalmology and Optometry

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 29, 2024Data synced to Clareo: May 16, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions